MVC’s vaccine plant, located in Hsinchu Science Park, was obtained the usage permit, on Oct 1st, issued by Hsinchu Science Park Bureau. MVC is expecting to obtain PIC/S GMP certification in 2016.
This multi-functional plant will incorporate capabilities from R&D, manufacturing, QC, to fill and finish. In addition, the plant is capable of manufacturing vaccines and biologics at the same time, aiming to fulfill unmet medical needs in vaccines and biopharmaceuticals.
Related news (in Chinese):